Yeah I was surprised by the design as well, but I’m sure they’ve worked out pre-clinically what level of CF33-CD19 is adequate for getting good coverage of CD19 on the tumours.
latest publication on the preclinical work -
https://pubmed.ncbi.nlm.nih.gov/38214445/
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-38
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $411.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2960 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 5500 | 1 |
View Market Depth
| Last trade - 09.55am 25/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable